Chapter 7: Reproductive Health, Menstrual Disorders, & STIs

Reproductive Health, Menstrual Disorders, & STIs begins with a detailed examination of the external genitalia, collectively known as the vulva, and the internal organs, including the vagina, uterus, uterine tubes, and ovaries, while also discussing the critical supportive role of the bony pelvis and the function of the breasts as mammary glands. A significant portion of the material is dedicated to the intricacies of the menstrual cycle, which is governed by a complex feedback system involving the hypothalamic-pituitary, ovarian, and endometrial cycles. This hormonal interplay, dominated by estrogen and progesterone, prepares the body for potential pregnancy and regulates the periodic shedding of the uterine lining. The text addresses common clinical concerns such as amenorrhea, which may stem from various endocrine disorders or the "female athlete triad," and primary dysmenorrhea, where the release of prostaglandins leads to painful uterine contractions. Detailed attention is given to premenstrual syndrome (PMS) and the more severe premenstrual dysphoric disorder (PMDD), highlighting the importance of lifestyle modifications and pharmacological interventions. The pathophysiology of endometriosis is explained, where endometrial tissue grows outside the uterus, often leading to chronic pelvic pain and infertility. The chapter also prioritizes the management of abnormal uterine bleeding (AUB) and the life transitions of perimenopause and menopause, emphasizing symptom relief and the risks associated with hormone therapy. Moving into infectious diseases, the text categorizes bacterial sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis, noting their rising rates in Canada and the potential for serious complications such as pelvic inflammatory disease (PID). Viral infections, including human papillomavirus (HPV), herpes simplex virus (HSV), various forms of hepatitis, and human immunodeficiency virus (HIV), are analyzed regarding screening protocols, vaccination, and long-term care. Furthermore, common vaginal infections like bacterial vaginosis, candidiasis (yeast infections), and trichomoniasis are differentiated by their diagnostic markers and treatments. The final section focuses on breast health, providing a clear distinction between benign conditions—such as fibrocystic changes and fibroadenomas—and the screening, risk assessment, and treatment of malignant breast cancer. Throughout the chapter, nursing roles are emphasized, focusing on patient education, risk reduction, and the promotion of culturally sensitive care and regular health screenings like Papanicolaou tests and mammography.